Log In
Print
BCIQ
Print
Print this Print this
 

Amitiza, lubiprostone (SPI-0211)

  Manage Alerts
Collapse Summary General Information
Company Sucampo Pharmaceuticals Inc.
DescriptionFunctional fatty acid chloride channel activator
Molecular Target Chloride channel
Mechanism of ActionCl channel activator
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today